{"id":34308,"date":"2023-01-05T16:16:49","date_gmt":"2023-01-05T15:16:49","guid":{"rendered":"https:\/\/ellipse.prbb.org\/?p=34308"},"modified":"2023-01-19T21:47:03","modified_gmt":"2023-01-19T20:47:03","slug":"nocturna-therapeutics-una-spin-off-dantivirals-dampli-espectre","status":"publish","type":"post","link":"https:\/\/ellipse.prbb.org\/ca\/nocturna-therapeutics-una-spin-off-dantivirals-dampli-espectre\/","title":{"rendered":"NoctuRNA Therapeutics: una spin-off d\u2019antivirals d&#8217;ampli espectre"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Les <a rel=\"noreferrer noopener\" href=\"https:\/\/ellipse.prbb.org\/ca\/elizabeth-diago-navarro-isglobal-aquesta-no-sera-la-darrera-pandemia-o-crisi-de-salut-publica-hem-destar-preparats\/\" target=\"_blank\">pand\u00e8mies v\u00edriques<\/a> s\u00f3n cada cop m\u00e9s comunes i l\u2019escenari, no tan futur, de <a rel=\"noreferrer noopener\" href=\"https:\/\/ellipse.prbb.org\/ca\/cathryn-tonne-isglobal-som-davant-una-emergencia-el-canvi-climatic-esta-aqui-i-ja-esta-afectant-a-la-salut-de-milions-de-vides\/\" target=\"_blank\">canvi clim\u00e0tic les afavorir\u00e0 cada cop m\u00e9s<\/a>. Aix\u00ed doncs, tenir a l\u2019abast de la comunitat cient\u00edfica una <strong>eina de disseny r\u00e0pid d\u2019antivirals<\/strong> seria molt \u00fatil per enfrontar-nos a elles. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>NoctuRNA Therapeutics<\/strong>, una nova <strong><a rel=\"noreferrer noopener\" href=\"https:\/\/ellipse.prbb.org\/ca\/prbbinnovation-el-punt-de-mira-en-la-transferencia-tecnologica\/\" target=\"_blank\">spin-off<\/a><\/strong> del Grup de Recerca en Virologia Molecular del <a rel=\"noreferrer noopener\" href=\"https:\/\/www.upf.edu\/web\/biomed\" target=\"_blank\">Departament de Medicina i Ci\u00e8ncies de la Vida de la Universitat Pompeu Fabra (MELIS-UPF)<\/a>, <a rel=\"noreferrer noopener\" href=\"https:\/\/www.upf.edu\/web\/guest\/inici\/-\/asset_publisher\/1fBlrmbP2HNv\/content\/neix-nocturna-therapeutics-una-spin-off-de-la-upf-que-desenvolupa-nous-antivirals-basats-en-una-plataforma-d-arn\/10193\/maximized\" target=\"_blank\">ha nascut<\/a> precisament per a generar <strong>antivirals basats en ARN circulars<\/strong> a una velocitat sense precedents.<\/p>\n\n\n\n<div style=\"height:23px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>\u201cGr\u00e0cies a la tecnologia de NoctuRNA Therapeutics s\u2019est\u00e0 desenvolupant una fam\u00edlia de medicaments amb un mecanisme d\u2019acci\u00f3 innovador que representa una gran millora respecte les altres opcions de mercat\u201d <br><strong><a href=\"https:\/\/ellipse.prbb.org\/ca\/juana-diez-dcexs-upf-oferim-informes-cientifics-que-ajudin-a-prendre-decisions-informades-sobre-politiques-de-salut\/\" target=\"_blank\" rel=\"noreferrer noopener\">Juana D\u00edez<\/a><\/strong>, <strong>MELIS-UPF<\/strong><\/p><\/blockquote>\n\n\n\n<div style=\"height:23px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">La nova plataforma, que porta darrere 7 anys de recerca, dissenyar\u00e0 <strong>f\u00e0rmacs d\u2019ampli espectre<\/strong> contra <a rel=\"noreferrer noopener\" href=\"https:\/\/ellipse.prbb.org\/ca\/els-virus-reprogramen-els-arnt-cellulars-per-a-maximitzar-la-produccio-viral\/\" target=\"_blank\">virus d\u2019ARN<\/a> gr\u00e0cies a un software propi basat en <strong><a rel=\"noreferrer noopener\" href=\"https:\/\/ellipse.prbb.org\/ca\/intel%c2%b7ligencia-artificial-el-camp-de-proves-definitiu\/\" target=\"_blank\">intel\u00b7lig\u00e8ncia artificial<\/a><\/strong>. Els antivirals, a m\u00e9s, es dirigiran directament al <strong>genoma v\u00edric<\/strong>, <strong>millorant la seva efic\u00e0cia<\/strong> i <strong>estabilitat <\/strong>i <strong>reduint<\/strong> l&#8217;aparici\u00f3 de <strong>resist\u00e8ncies v\u00edriques<\/strong> i les possibilitats de patir efectes no desitjats. I ser\u00e0, tamb\u00e9, una eina molt vers\u00e0til: actualment l&#8217;equip estudia, en fase precl\u00ednica, virus hep\u00e0tics (hepatitis C i E) i respiratoris (com el <a rel=\"noreferrer noopener\" href=\"https:\/\/ellipse.prbb.org\/ca\/tag\/coronavirus-ca\/\" target=\"_blank\">SARS-CoV-2<\/a>). I fins i tot est\u00e0 desenvolupant un ARN circular pel tractament d&#8217;una malaltia gen\u00e8tica (i per tant no causada per virus), la diabetis DM1.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A banda de la seva rapidesa (<strong>s\u2019obtindran antivirals en menys d\u2019un mes<\/strong> despr\u00e9s de la seq\u00fcenciaci\u00f3 del genoma del virus), NoctuRNA Therapeutics destaca pel seu <strong>enfocament terap\u00e8utic<\/strong> i no preventiu, com \u00e9s el cas d&#8217;altres empreses del mercat que s&#8217;enfoquen en vacunes.<\/p>\n\n\n\n<div style=\"height:46px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>El MELIS-UPF llan\u00e7a una nova spin-off, NoctuRNA Therapeutics, que dissenyar\u00e0 antivirals d&#8217;ampli espectre a partir d&#8217;ARN circulars en menys d&#8217;un mes.<\/p>\n","protected":false},"author":29,"featured_media":34310,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[555,721,233,726,273,475],"new-type":[35,43],"class_list":["post-34308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recerca","tag-arn","tag-coronavirus-ca","tag-farmacologia","tag-innovacio","tag-melis-upf-ca","tag-virus-ca","new-type-noticies","new-type-recomanem"],"acf":[],"_links":{"self":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/34308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/comments?post=34308"}],"version-history":[{"count":16,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/34308\/revisions"}],"predecessor-version":[{"id":34369,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/34308\/revisions\/34369"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media\/34310"}],"wp:attachment":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media?parent=34308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/categories?post=34308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/tags?post=34308"},{"taxonomy":"new-type","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/new-type?post=34308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}